Immunology

This year’s prestigious GlaxoSmithKline Australia Award for Research has gone to Monash University’s Professor Charles Mackay for his work on immunology and inflammation, particularly the discovery of GPR43 as a major regulator of innate and inflammatory response.

Back when Living Cell Technologies's (LCT) current Medical Director and Founder, Professor Bob Elliott, was working in his Auckland clinic, he decided that the treatments available for patients with Type I diabetes simply weren't good enough.

Researchers from Sydney's Garvan Institute have challenged the dominant view in immunology circles as to how a special type of immune cell, called a T follicular helper cell (Tfh), is generated.

Monash University has announced the appointment of esteemed Australian scientist and medical researcher Professor Scott O’Neill as the University’s new Dean of Science.

The world market for treatments addressing allergic rhinitis will shrink by 20 percent to $US4 billion over the next 10 years as increasing numbers of generic products come to market, according to industry analysts Datamonitor.

Professor Andrew Lloyd of the University of New South Wales is one of the central figures in the HITS study (Hepatitis C Incidence and Transmission Study) is a long-term prospective cohort study of eligible prison inmates in NSW. Lloyd’s cohort comprises high-risk, uninfected injecting drug users, who are followed at regular intervals longitudinally.

A study by Sydney researchers showing that the protease inhibitor type of HIV drugs carry a greater risk of heart attack than the new integrase inhibitor family of drugs is expected to have major implications for the future direction of treatment.

The July/August edition of Australian Life Scientist is out now. The issue takes an in-depth look at the happenings at the upcoming Human Proteome Organisation (HPUO) 2010 World Congress, which will host the launch of the long awaited Human Proteome Project.

Brisbane-based molecular diagnostics company, Athlomics, has provided the first of its SeptiCyte Lab kits for the diagnosis of sepsis to Brisbane’s Mater Pathology.